James Dolan and Madison Square Garden have lost a legal fight against the New York State Liquor Authority after a judge threw out MSG’s lawsuit against the New York State Liquor Authority.
NEW YORK – Madison Square Garden CEO James Dolan is back in the headlines again, this time after losing a legal fight against the New York State Liquor Authority.
Dolan may have tripped himself up in an interview on FOX 5 NY's Good Day New York in January.
"They're being extremely aggressive and they're saying we're gonna take away your liquor license," Dolan told GDNY.
RELATED: MSG sues NY Liquor Authority over alcohol ban threat
The interview, however, may have helped convince a state supreme court judge to throw out MSG's lawsuit against the Liquor Authority. MSG CEO James Dolan On The Record
James Dolan, CEO of MSG Entertainment defended his use of facial recognition in an exclusive interview on FOX 5’s Good Day New York. For more: https://www.fox5ny.com/news/msg-lawyer-ban-anti-bias-laws-madison-square-garden
Last month, MSG sued the Liquor Authority after it warned MSG that it was going to possibly revoke its liquor license over MSG's use of facial recognition technology to identify and ban lawyers from MSG, Radio City Music Hall, and the Beacon Theatre if their law firms are involved in lawsuits against any of the venues.
RELATED: Appeals court: Madison Square Garden can ban lawyers suing them from entry
MSG had claimed it would suffer financially if its liquor license was pulled, but on Good Day New York Dolan said "People are still gonna come to the games and, you know, honestly yes alcohol, but we don't make, we don't make all our money on alcohol."
The judge quoted this comment in his decision to dismiss MSG's lawsuit, saying it raised doubt that MSG would be harmed if its liquor license was taken away.
"The SLA will continue our disciplinary process to ensure that MSGE complies with its duties under the law," the Liquor Authority said after Wednesday's decision.
Meanwhile, MSG says it will continue to block certain lawyers from its venues.
"While the judge denied our filing as ‘premature,’ this decision has no impact on our enforcement of our policy, which we will continue to vigorously defend," MSG said in a statement.
British star Lesley Manville and American actor John Lithgow have won the acting categories at this year’s Olivier Awards, which recognise excellence in London theatre.
Lithgow, 79, played Roald Dahl in Giant, which is about the children’s author wondering whether to make a public apology.
While accepting his award he appeared to reference the current controversy over Donald Trump’s second term as US president.
The Conclave star quipped: “It’s not always easy to welcome an American into your midst, and at this particular moment, it’s probably a little more complicated than usual.”
He also told the audience at the Royal Albert Hall that the “special relationship is still firmly intact”, despite Mr Trump imposing tariffs on British exports to the US.
His co-star, English actor Elliot Levey, took best actor in a supporting role.
Giant was also named best new play.
Image: Lesley Manville was best actress. Pic: PA
Manville, 69, was honoured for her performance in the Greek tragedy Oedipus at the Wyndham’s Theatre.
She said she felt “emotional” while accepting her statuette because it was a production she had “felt very strongly about being” in.
Manville, who played Princess Margaret in The Crown, added that she was taking an early flight to Dublin on Monday to do some filming, and would not be getting “much sleep tonight”.
Image: Romola Garai was best actress in a supporting role. Pic: PA
Best actress in a supporting role went to Romola Garai for her performance in The Years, based on a memoir by French writer Annie Ernaux.
Garai, whose film credits include Scoop and Atonement, was nominated in the same category for Giant.
Image: Elliot Levey was best actor in a supporting role. Pic: PA
Dame Imelda Staunton won a fifth Olivier, for best actress in a musical for the London revival of classic musical Hello, Dolly!
The Curious Case Of Benjamin Button won best new musical, a best actor musical award for Lark Rise To Candleford actor John Dagleish, and the outstanding musical contribution award.
The annual event was co-hosted by British singer Beverley Knight and Pose star Billy Porter.
The suspended surgeon at Addenbrooke’s Hospital in Cambridge has been named as paediatric consultant Kuldeep Stohr.
Eight hundred patients operated on by Ms Stohr are having their cases urgently re-examined, after an external review found nine children whose care fell below expected standards.
The initial review was ordered after concerns were raised by her colleagues.
Sky News has seen a copy of the interim report which details several issues relating to complex hip surgeries performed by the surgeon.
One of the parents whose child was identified in the review showed us a recent letter from the hospital which reported“problems with both judgement and technique” in her child’s surgery.
Ms Stohr, who has been suspended since the end of January, said in a statement: “I always strive to provide the highest standards of care to all my patients.
“I am co-operating fully with the trust investigation and it would not be appropriate to comment further at this time.”
Image: Tammy Harrison: ‘It was hell’
Left in agonising pain
Tammy Harrison, 12, has cerebral palsy and had surgeries carried out by Ms Stohr. Her operations didn’t work, leaving her in agonising pain.
She said: “My first one was just like trauma. I couldn’t get out of bed for eight weeks. I was either stuck in bed or stuck on the sofa. It was hell.”
Her mum, Lynn, told Sky News: “There is nothing that can put Tammy back to where she was now and that’s the sad thing.
“If I could just click my fingers and have the child back that I had I would do it with a blink of an eye.”
Image: Ms Stohr operated on Lynn Harrison’s daughter
So far, there’s been no confirmation of any wrongdoing in Tammy’s care.
But her family have a meeting at the hospital this week to find out more.
The trust has asked a panel of specialist clinicians to review all the planned operations carried out by Ms Stohr at Addenbrooke’s. One hundred emergency trauma cases will also be looked at.
Addenbrooke’s is a major regional trauma centre and treats serious emergency patients from all over the region.
One clinician at the hospital told Sky News that the review of so many patients was “creating a lot of extra work”, which was “slowing things down” for other patients awaiting treatment.
Image: Addenbrooke’s Hospital. File pic: PA
At least one extra locum consultant has been helping the team, as they work through the caseload.
Trust apologises
Sky News has been told Cambridge University Hospitals Trust had wanted to identify Ms Stohr before but had been threatened with a legal injunction.
The trust has apologised unreservedly to families and patients. But what’s troubling many is the fact concerns were raised about Ms Stohr a decade ago.
Chief executive of Cambridge University Hospitals Trust, Roland Sinker, has set up another review to examine whether opportunities were missed, and action could have been taken sooner.
The Department of Health described the ongoing situation as “incredibly concerning.”
A view shows disused oil pump jacks at the Airankol oil field operated by Caspiy Neft in the Atyrau Region, Kazakhstan April 2, 2025.
Pavel Mikheyev | Reuters
U.S. oil prices dropped below $60 a barrel on Sunday on fears President Donald Trump’s global tariffs would push the U.S., and maybe the world, into a recession.
Futures tied to U.S. West Texas intermediate crude fell more than 3% to $59.74 on Sunday night. The move comes after back-to-back 6% declines last week. WTI is now at the lowest since April 2021.
Worries are mounting that tariffs could lead to higher prices for businesses, which could lead to a slowdown in economic activity that would ultimately hurt demand for oil.
Stock Chart IconStock chart icon
Oil futures, 5 years
The tariffs, which are set to take effect this week, “would likely push the U.S. and possibly global economy into recession this year,” according to JPMorgan. The firm on Thursday raised its odds of a recession this year to 60% following the tariff rollout, up from 40%.